ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Everolimus
C53H83NO14
958.2 g/mol
APIDanger

Everolimus

CAS159351-69-6
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material

Everolimus is an active pharmaceutical ingredient used as an immunosuppressive agent. It is a macrocyclic compound with multiple hydroxyl and ether groups, characterized by a complex stereochemical structure.

immunosuppressive agent

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 159351-69-6

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongStructure SimilarSimilarity 0.87

Sirolimus

CAS53123-88-9

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.87

Sirolimus Impurity 2

CAS157182-37-1

Pharmaceutical impurity reference standard

SimilarStructure SimilarSimilarity 0.85

Temsirolimus

CAS162635-04-3

pharmaceutical raw material

ReferenceSame Category

4-{[(2-Amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol--hydrogen chloride (1/1)

CAS15942-05-9

pharmaceutical raw material

ReferenceSame Category

Enfuvirtide

CAS159519-65-0

pharmaceutical raw material

ReferenceSame Category

Tesirin

CAS1595275-62-9

pharmaceutical raw material

ReferenceSame Category

Ibutamoren mesylate

CAS159752-10-0

pharmaceutical raw material

Safety Reference

Health Hazard
Health Hazard
Environmental Hazard
Environmental Hazard
Danger
H372Causes damage to organs through prolonged or repeated exposure
H412Harmful to aquatic life with long lasting effects
H402Harmful to aquatic life
Identifiers
IUPAC Name

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

InChIKey

HKVAMNSJSFKALM-GKUWKFKPSA-N

SMILES

C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC

Synonyms (34)
  • RAD
  • SDZ-RAD
  • TORPENZ
  • Everolimus (INN)
  • 001, RAD
  • Afinitor
  • Afinitor Disperz
  • Certican
  • EVE - Everolimus
  • EVEROLIMUS [MART.]
  • Everolimus
  • Everolimus (RAD001)
  • Everolimus (Standard)
  • Everolimus (~90% pure)
  • Everolimus CRS
  • Everolimus tablets
  • Everolimus; RAD001; SDZ-RAD
  • RAD, SDZ
  • Votubia
  • XIENCE V
  • Zortress
  • everolimusum